MEG3 and colorectal carcinoma: This panel consisted of 7 upregulated molecules (CCAT1, CCAT2, H19, HOTAIR, HULC, MALAT1, PCAT1) and 3 downregulated molecules (MEG3, PTENP1, TUSC7) in patients with CRC [124].